A new drug intended for the treatment of mental illnesses, including obsessive thoughts, and schizophrenia, it was developed by Russian scientists from the Institute of pharmacology named after V. A. Waldman, a part of the medical University named after academician Pavlov in St. Petersburg.
According to one of the authors of the study Ilya Sukhanov, St. Petersburg scientists have created a substance that can affect the dopamine europeradio.
“The rodents were injected with a compound that activates TAAR1 receptors of the Central nervous system. Thus was the influence on the transmission of signals between neurons in the brain”, – told specialist about testing the new connection.
It also became known that created by Russian scientists the composition is tested as a new drug to combat schizophrenia. If this test is successful, testing will move into the clinical stage. But today, scientists say with confidence that created the St. Petersburg researchers, drug formula will allow you to develop tablets for the treatment of mental disorders, as well as new methods of treatment of the schizophrenia. The data obtained after experiments with animals, give reason to believe that a new drug will be effective against those people who are characterized by obsessive-compulsive disorder.
Schizophrenia is a severe mental disorder which worldwide affects more than 21 million people. This disease is characterized by disturbances in thinking, perception, emotion, language, self-perception and behavior. Common symptoms of schizophrenia are hearing voices and delusional state.
We will remind, a year earlier, the chief freelance psychiatrist of the Department of health of Moscow Georgy Kostyuk said that in Russia up to 2030 will see an increase in the number of mental disorders – suffering disorders of the psyche of the Russians will be more than 20%. The growth of border-line mental disorders linked to the pressure of the environment, said the psychiatrist.
Earlier Magicforum wrote about the fact that the Russians have record a new mental illness.